Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Huntington Disease
 More »

  • Drug Candidates on Trial
    ... Huntington's Disease > Auspex Pharmaceuticals enrolled the first patient in a multicenter ... the treatment of involuntary movements (chorea) associated with Huntington's disease (HD). ...
    7-22-2013
  • Aphios, VivaCell to Develop Cannabinoid-Based Drugs for MS, CNS...
    in well-defined animal models of multiple sclerosis and Huntington's disease." ... Parkinson's, and Alzheimer's disease," according to Trevor P. Castor, Ph.D., ...
    6-12-2013
  • Why Junk Is Good for the Brain
    noncoding RNAs and Huntington's disease. He also found weaker associations between specific groups of long noncoding RNAs and Alzheimer's disease, convulsive seizures, major ...
    4-16-2013
  • Roche and Isis Pharmaceuticals Set Sights on Huntington's
    for Huntington's disease (HD) based on Isis' antisense oligonucleotide (ASO) technology. ... Huntington's disease is an inherited genetic brain disorder that results in the ...
    4-8-2013
  • Potential Prion Disease Therapy Uncovered
    in treating fatal disorders, such as Creutzfeldt-Jakob disease (the human equivalent of mad cow disease), says the team at the Florida campus of The Scripps Research Institute. ...
    4-4-2013
  • Stem Cell Lines
    NSW 2000 Genea Stem Cells (GSC) develops disease-specific pluripotent and differentiated ... GSC supplies application-ready, disease-affected and control differentiated cell ...
    3-15-2013
  • Zapping Pathological Proteins in Alzheimer's
    AC Immune Takes Aim at Misfolded Abeta and Tau, as Firm Eyes Disease Prevention AC ... AC Immune is fighting Alzheimer's disease on three fronts armed with monoclonal ...
    3-1-2013
  • New Method Enables Multiplex Genome Engineering
    to study human disease, and to develop new therapies, among other potential applications. ... new therapies for diseases such as Huntington's disease, caused by a single abnormal gene. ...
    1-3-2013
  • Evotec Acquires Cell Supplier
    in recent months with Bayer (endometriosis) and CHDI Foundation (Huntington's disease); "significant" milestone revenue from Andromeda/Teva, Boehringer Ingelheim, and ...
    1-3-2013
  • The New Economics of Orphan Diseases
    Opportunities Abound in Rare Disease Space as Market Is Projected to Continue Growing Top ... waivers attract multinational corporations to the rare disease segment," Munjal explains. ...
    1-1-2013
  • Nuron, Raptor in Royalty Deals
    marketed for prevention of invasive disease caused by Neisseria meningitidis ... RP103 is also in clinical development for the potential treatment of Huntington's disease ...
    12-20-2012
  • Genmab Reaches Third Rung in Lundbeck Collab
    to aid preclinical development of Lundbeck's Huntington's disease therapeutic candidate, particularly focusing on the compound's effects on P2X receptors implicated in the disease. ...
    12-13-2012
  • uniQure and Benitec Enter Cross-Licensing Agreement
    to Benitec's DNA-directed RNA interference (ddRNAi) technology in Huntington's disease. ... that lies at the basis of Huntington's disease, and to develop a therapy for this ...
    12-5-2012
  • Screen Reveals Hundreds of Potential HD Targets
    to toxicity associated with Huntington's disease (HD), hoping that some of them may lead ... genes that seem to be modifying the Huntington toxicity phenotype, where we can start ...
    11-30-2012
  • Horizon Applies Gene Editing to Huntington's Disease
    The partnership will focus on the creation of human isogenic disease model cell lines with insertion of Huntington's disease-causing triplet repeats. The company will provide UCL ...
    11-8-2012
  • More »

    Journal Articles

  • Regulation and Physiologic Functions of GTPases in Mitochondrial...
    Naotada Ishihara, Hidenori Otera, Toshihiko Oka, Katsuyoshi Mihara
    Antioxidants & Redox Signaling
    Defects of these mechanisms cause various disorders, including neurodegenerative diseases such as Parkinson's disease, Huntington's disease, and Alzheimer's disease. Critical ...
  • Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal...
    Alexis-Pierre Bemelmans, Philippe Horellou, Laurent Pradier, Isabelle Brunet, Philippe Colin, Jacques Mallet
    Human Gene Therapy and Part B: Methods
    Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene Transfer Human ...
  • Identification and Allele-Specific Silencing of the Mutant Huntingtin...
    P.H.J. van Bilsen, L. Jaspers, M.S. Lombardi, J.C.E. Odekerken, E.N. Burright, W.F. Kaemmerer
    Human Gene Therapy and Part B: Methods
    Identification and Allele-Specific Silencing of the Mutant Huntingtin Allele in Huntington's Disease Patient-Derived Fibroblasts Human Gene Therapy and Part B: Methods
  • Palliative Care for Patients with Huntington's Disease #201
    Sean Marks, Serena Hung, Drew A. Rosielle
    Journal of Palliative Medicine
    Palliative Care for Patients with Huntington's Disease #201 Journal of Palliative Medicine

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll